User talk:Qmpotential

This is Qmpotential's talk page, where you can send them messages and comments.

Put new text under old text. Click here to start a new topic.
New to Wikipedia? Welcome! Learn to edit; get help.

Your submission at Articles for creation: 1,3-dimethylimidazolium nitrate (February 4)

Your recent article submission to Articles for Creation has been reviewed. Unfortunately, it has not been accepted at this time. The reason left by The Herald was:

This submission reads more like an essay than an encyclopedia article. Submissions should summarise information in secondary, reliable sources and not contain opinions or original research. Please write about the topic from a neutral point of view in an encyclopedic manner.

The comment the reviewer left was:

Needs rewrite and fixing of those external links.

Please check the submission for any additional comments left by the reviewer. You are encouraged to edit the submission to address the issues raised and resubmit after they have been resolved.

If you would like to continue working on the submission, go to Draft:1,3-dimethylimidazolium nitrate and click on the "Edit" tab at the top of the window.
If you do not edit your draft in the next 6 months, it will be considered abandoned and may be deleted.
If you need any assistance, or have experienced any untoward behavior associated with this submission, you can ask for help at the Articles for creation help desk, on the reviewer's talk page or use Wikipedia's real-time chat help from experienced editors.

The Herald (Benison) (talk) 10:34, 4 February 2024 (UTC)[reply]

Hello, Qmpotential! Having an article draft declined at Articles for Creation can be disappointing. If you are wondering why your article submission was declined, please post a question at the Articles for creation help desk. If you have any other questions about your editing experience, we'd love to help you at the Teahouse, a friendly space on Wikipedia where experienced editors lend a hand to help new editors like yourself! See you there! The Herald (Benison) (talk) 10:34, 4 February 2024 (UTC)[reply]

Your submission at Articles for creation: 1,3-dimethylimidazolium nitrate has been accepted

1,3-dimethylimidazolium nitrate, which you submitted to Articles for creation, has been created.

Congratulations, and thank you for helping expand the scope of Wikipedia! We hope you will continue making quality contributions.

The article has been assessed as Start-Class, which is recorded on its talk page. Most new articles start out as Stub-Class or Start-Class and then attain higher grades as they develop over time. You may like to take a look at the grading scheme to see how you can improve the article.

Since you have made at least 10 edits over more than four days, you can now create articles yourself without posting a request. However, you may continue submitting work to Articles for creation if you prefer.

If you have any questions, you are welcome to ask at the help desk. Once you have made at least 10 edits and had an account for at least four days, you will have the option to create articles yourself without posting a request to Articles for creation.

If you would like to help us improve this process, please consider leaving us some feedback.

Thanks again, and happy editing!

Graeme Bartlett (talk) 21:29, 9 February 2024 (UTC)[reply]

Ways to improve 1,3-Dimethylimidazolium nitrate

Hello, Qmpotential,

Thank you for creating 1,3-Dimethylimidazolium nitrate.

I have tagged the page as having some issues to fix, as a part of our page curation process and note that:

This compound is not widely cited, and appears to be largely unstable so why there should ba an article on it is not obvious.

The tags can be removed by you or another editor once the issues they mention are addressed. If you have questions, leave a comment here and begin it with {{Re|Ldm1954}}. Remember to sign your reply with ~~~~. For broader editing help, please visit the Teahouse.

Delivered via the Page Curation tool, on behalf of the reviewer.

Ldm1954 (talk) 03:05, 13 February 2024 (UTC)[reply]